|
|
|
Summary
of 1999 CPCRA Posters and Presentations
| Fifth Workshop on Case Studies in Bayesian Statistics, September 24-25, 1999 |
Tsai C, Chaloner K. Using prior opinions to examine sample size in two clinical trials. Poster.
| The Fourth International Conference on Home and Community Care for Persons Living With HIV/AIDS, December 5-11, 1999, Paris, France |
Turner M, Roane R, Munroe D, Petrovic L, Besch CL, Gordin F. Community representatives as
partners: Bridging the gap between people with AIDS (PWAs) and researchers for effective
transmission of research results in the Terry Beirn Community Programs for Clinical Research on
AIDS (CPCRA). December 11, 1999; Poster.
| The 1999 National Conference on Women and HIV/AIDS, October 9-12, 1999, Los Angeles, CA |
El-Sadr W, Bebchuk JD. The effect of gender on progression of HIV disease. Poster.
| Society for Clinical Trials, May 2-5, 1999 |
Chaloner, K. A clinical trial examining acupuncture for the treatment of HIV associated pain:
Results and lessons learned. Oral.
| 9th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC),
September 27, 1999, San Francisco, CA |
El-Sadr W, Mannheimer S, Grant L, Matts J. Use of PCP and MAC prophylaxis
among eligible patients with and without CD4+ rebound. Poster.
El-Sadr W, Eberly LE, Cohn D. Mortality associated with the occurrence of HIV-related
opportunistic diseases (ODs) prior to and since HAART. Poster.
Fisher E, Cohn D, Chaloner K, Grant L, Brosgart C, El-Sadr W, Alston B, Schmetter B. Effect of
adefovir dipivoxil (ADV) on hepatitis B (HBV) viral load (VL) in a subset of HIV+ patients (pts)
from a randomized trial of ADV in advanced HIV disease. Oral.
| 3rd International Workshop on Drug Resistance & Treatment Strategies, June 23-26, 1999 |
Baxter JD, Mayers DL, Wentworth DN, Neaton JD, Merigan TC, and the CPCRA 046 Study Team.
Final results of CPCRA 046: A pilot study of antiretroviral management based on plasma genotypic
antiretroviral resistance testing (GART) in patients failing antiretroviral therapy. Oral.
Mayers DL, Baxter JD, Wentworth DN, Neaton JD, Merigan TC and the CPCRA 046 Study Team.
The impact of drug resistance mutations in plasma virus of patients failing on PI-containing HAART
regimens on subsequent virologic response to the next HAART regimen: Results of CPCRA 046
(GART). Poster.
| 3rd International Workshop on Drug Resistance & Treatment Strategies, June 23-26, 1999 |
Gibert C, Raghavan S, Wheeler D, Collins G, Muurahainen N, Madans M, Williams B, Alston B,
Bartsch G for the CPCRA 038 Team. The effect of caloric supplements on weight and body cell
mass in HIV-infected individuals with CD4 <200 cells/mm3 (CPCRA 038). Poster.
Gibert C, Muurahainen N, Collins G, Williams B, Raghavan S, Bartsch G, Wheeler D. Body
composition in HIV-infected men and women in 1996-1997. Poster.
| 3rd International Cohorts Meeting, June 9-10, 1999, Verona, Italy |
Bartsch G, Krum E, Neaton J, Chen L, Collins G, Kostman J. Methods of collection of metabolic and
cardiovascular toxicities of HAART in the CPCRA. Oral.
| ALA/ATS International Conference, April 23-28, 1999, San Diego, CA |
El-Sadr W, Perlman DC, Nelson E, Matts J. Outcome of 6 months therapy for HIV-related
tuberculosis (HIV/TB). Poster.
| 6th Conference on Retroviruses and Opportunistic Infections, January 31-February 4, 1999, Chicago, IL |
Fisher E, Brosgart C, Cohn D, Chaloner K, Pulling C, Alston B, Schmetter B, El-Sadr, W, CPCRA
039 Team. Placebo (PLC)-controlled, multicenter trial of adefovir dipivoxil (ADV) in patients
(PT) with HIV disease. Oral.
Fisher E, Brosgart C, Cohn D, Chaloner K, Pulling C, Schmetter B, Alston B, El-Sadr W, CPCRA
039 Team. Safety of adefovir dipivoxil (ADV) and incidence of proximal renal tubular disorder
(PRTD) in a placebo (PLC)-controlled trial in patients (PT) with advanced HIV disease. Poster.
El-Sadr W, McCabe-Yurik T, Murphy R. Intolerance (INT) to atovaquone (ATQ) and dapsone
(DAP) and the impact of prior type of INT to trimethoprim/sulfamethoxazole (TMS). Poster.
Brosgart C, Fisher E, Pulling C, Chaloner K, Cohn D, El-Sadr W, Verheggen R, Schmetter B, Alston
B. Prevalence of asymptomatic CMV retinitis (CMVR) in AIDS patients. Poster.
Brosgart C, Fisher E, Pulling C, Chaloner K, Cohn D, El-Sadr W, Verheggen R, Schmetter B, Alston
B. Prevalence of asymptomatic CMV retinitis (CMVR) in AIDS patients. Poster.
Gordin F, Matts J, Miller C, Chaisson R, Garcia M, O'Brien R for the CPCRA/ACTG/DCD/PAHO
Study Team. Risk factors for developing active tuberculosis (TB) among HIV-infected, PPD-
positive (+)patients (pts). Poster.
Baxter JD, Mayers DL, Wentworth DN, Neaton JD, Merigan TC and the CPCRA 046 Study Team.
A pilot study of the short-term effects of antiretroviral management based on plasma genotypic
antiretroviral resistance testing (GART) in patients failing antiretroviral therapy. Oral.
|
|
